ANI Pharmaceuticals
ANIP
ANIP
277 hedge funds and large institutions have $1.79B invested in ANI Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 109 increasing their positions, 83 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
4% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 47
2% less funds holding
Funds holding: 283 → 277 (-6)
51% less call options, than puts
Call options by funds: $15.6M | Put options by funds: $32.1M
Holders
277
Holding in Top 10
3
Calls
$15.6M
Puts
$32.1M
Top Buyers
| 1 | +$52.1M | |
| 2 | +$27.1M | |
| 3 | +$26.1M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$17.6M |
| 5 |
SCM
Sio Capital Management
New York
|
+$13.9M |
Top Sellers
| 1 | -$17.9M | |
| 2 | -$16.2M | |
| 3 | -$15.5M | |
| 4 |
Goldman Sachs
New York
|
-$14.1M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$10.1M |
